Hacking goes squishy
By The Economist,
The Economist
| 09. 03. 2009
MANY of the world’s great innovators started out as hackers—people who like to tinker with technology—and some of the largest technology companies started in garages. Thomas Edison built General Electric on the foundation of an improved way to transmit messages down telegraph wires, which he cooked up himself. Hewlett-Packard was founded in a garage in California (now a national landmark), as was Google, many years later. And, in addition to computer hardware and software, garage hackers and home-build enthusiasts are now merrily cooking up electric cars, drone aircraft and rockets. But what about biology? Might biohacking—tinkering with the DNA of existing organisms to create new ones—lead to innovations of a biological nature?
The potential is certainly there. The cost of sequencing DNA has fallen from about $1 per base pair in the mid-1990s to a tenth of a cent today, and the cost of synthesising the molecule has also fallen. Rob Carlson, the founder of a firm called Biodesic, started tracking the price of synthesis a decade ago. He found a remarkably steady decline, from over $10 per base pair...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Katrina Miller, The New York TImes | 02.05.2026
Joseph Yracheta: The Native Biodata Consortium is the first nonprofit data and sample repository within the geographic bounds and legal jurisdiction of an American Indian nation, on the Cheyenne River Sioux Reservation in Eagle Butte, S.D.
NativeBio participated in a ...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...